Clinical trial

Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy

NCT00418080

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-04-01

PhasePHASE2

Study timeline

Study start (unknown)2002-04-01Date precision: month

Registry last updated2007-10-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

bicalutamideDRUG · verified · RxNorm: bicalutamide

Sponsors & collaborators

University of L'Aquilalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00418080 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.